Technology vendors, pharmacists, health insurers and pharmaceutical companies are choosing to form alliances to ensure that their interests in the growing ePrescribing sector are secured. This Brief examines the benefits to pharmaceutical companies involved in ePrescribing and examines the interaction between the major players who are interested in establishing a presence in this growing market.
Scope:
- Case studies illustrating current ePrescribing systems and highlighting the opportunity for cross-sector alliances
- Country coverage: US and UK
Report Highlights:
In the US, pharmaceutical companies should look to partner with technology vendors in order to ensure that they have a central role in the development of ePrescribing systems
Pharmaceutical companies should play a role in developing measurement tools to prove the efficiency gains for physicians, one of the key resistors in uptake of ePrescribing
Reasons to Purchase:
- Evaluate the current events that are driving the ePrescribing market
- Understand the role of key market players and the levels of interaction between them
- Realize the opportunities for pharmaceutical companies to play a role in the ePrescribing process
